Sagent Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Levetiracetam Injection, USP Due to Lack of Sterility Assurance

Date: 11/22/2021

Product type: Drugs, Potential Lack of Sterility

Company Announcement Date: November 19, 2021
FDA Publish Date: November 22, 2021
Product Type: Drugs
Reason for Announcement: Lack of sterility assurance
Company Name: Sagent Pharmaceuticals, Inc.
Brand Name: Sagent
Product Description: Levetiracetam Injection

US-FDA Link: